President & CEO
Todor Jeliaskov brings over 20 years of experience solving customers’ needs and generating returns for investors and shareholders at large, complex enterprises and startup organizations across continents and various industries. Before inHEART, Todor Jeliaskov was CEO of NuVera Medical, acquired by Biosense Webster (Johnson & Johnson) in November 2020. NuVera developed the next-generation intracardiac imaging technology for cardiac interventions - 4D ICE. Todor Jeliaskov previously served as VP at GE Ultrasound - the worldwide market leader in diagnostic ultrasound. Todor Jeliaskov started his career at Siemens Medical Solutions. He holds a Ph.D. in Electrical Engineering and an MBA degree.
CTO
With an engineering degree from ISEN (Brest, France), Loïc began his career conducting research on image contrast enhancement in the mammography department at General Electric (Buc, France). After that, he spent 5 years at INRIA, a research institute (Sophia-Antipolis, France) developing a cross-platform medical image processing and visualization software. This is where he started working on the MUSIC (Multi-modality Platform for Specific Imaging in Cardiology) project, which eventually gave birth to inHEART. He joined inHEART in 2017 as a developer, then managed the Development team, and is now CTO.
Eager to improve his skills in the cardiac field, he passed a University Diploma in Cardiac Electrophysiology at the University of Montpellier in 2020.
Director of Production, Clinical & Sales Development France
Bruno brings 20 years of experience in medical imaging acquisition as CT and MR technician at Bordeaux University Hospital. After a research project in collaboration with the cardiac electrophysiology department, he joined inHEART in 2017 to manage the cardiac imaging analysis department. Interested in developing his skills, he complemented his education with a university diploma in Cardiac Electrophysiology in Montpellier University in 2020. Bruno Soré started his career in the department of nuclear medicine imaging at the University of Bordeaux hospital, eventually moving into the cardiac imaging department.
International Business Development Manager
Nastasia brings strong experience in international trade, project management, and organizational skills to the inHEART team. She has 5 years experience in the Environment Health for Children organization and today assists the international sales team at inHEART. In close collaboration with her colleagues, she assists customers in their administrative procedures and supports the sales organization in execution of the inHEART commercial strategy.
Quality & Regulatory Affairs Manager
Laure holds a Master’s degree in Chemistry with a specialization in Quality from the University of Bordeaux. After an initial academic background in chemistry, she began her career in Quality Assurance. Her early professional experiences inspired her to deepen her knowledge of quality and regulatory frameworks, leading her to resume her studies and specialize in quality management systems. Over the past 10 years, Laure has developed solid expertise in Quality & Regulatory Affairs, particularly in the field of medical devices. Her dual experience—both in-house and as an independent consultant—has given her a comprehensive understanding of the operational and strategic challenges of regulatory compliance.
She joined inHEART in 2022 as a QARA Engineer and has since been actively involved in maintaining and improving the company’s quality system, as well as ensuring the regulatory compliance of inHEART’s products. After three years, she has naturally stepped into the role of Manager and now leads the QARA team at inHEART. Her role is to ensure compliance of the Quality Management System and Technical Documentation with applicable regulations, and to maintain market access in Europe, North America, and Australia.
US Market Development Consultant
Dave has been an active member of the cardiac electrophysiology community for over 30 years. In 1991, as an employee of Quinton Electrophysiology Systems, he had the opportunity to meet many emerging leaders in the field. In 1996, Dave joined Cardiac Pathways’ product development team, where he supported enrollment of a randomized controlled trial evaluating the safety and efficacy of an irrigated catheter system for ablating ventricular tachycardia. In 2001, after the acquisition by Boston Scientific, Dave supported its domestic and international initiatives. Next, at Voyage Medical (2006), in the capacity of VP of Clinical Marketing, he assisted in the development of a cardiac ablation direct visualization system. In 2012, Dave became an independent consultant, introducing emerging technologies to clinicians in the United States and OUS markets. He joined the inHeart Medical team in 2015.
Director of Sales and Clinical Development
David Gareau brings over 15 years of medical device and startup experience to the inHEART team. He has worked in electrophysiology at all stages of product development from initial planning, pre-clinical studies, first-in-human, clinical research, product launch and commercial sales and support. David has worked with both startups and large global medical device organizations.
Prior to joining inHEART David worked with Biosense Webster focused on their clinical and commercial efforts utilizing the Carto mapping system and catheter solutions. He then joined Galvanize Therapeutics and assisted in the development, clinical research, and commercialization of their pulsed electric field (PEF) solutions. David has lived, studied, and worked in South America, North America and Europe. He has university degrees in computer science, biology and is a registered nurse.
US Clinical Sales Representative
Matt brings extensive medical device and startup experience to the inHEART team. He began his career with Stereotaxis, providing sales and clinical support to electrophysiologists using robotics to treat complex arrhythmias. This experience sparked his passion for innovative technology and deepened his knowledge of electrophysiology. He later joined Avertix, where he focused on the commercial development of their cardiac monitoring devices. Matt’s experience has provided him the opportunity to develop his skills and industry knowledge, ensuring top-tier customer service.
US Clinical Sales Consultant
Kevin brings over 15 years of electrophysiology experience to the inHEART team. His initial work as a technologist in the EP lab helped shape his patient centered approach to the cardiac industry. Mapping arrhythmias for Biosense Webster, Abbott and Acutus deepened his knowledge for electrophysiology, cardiac anatomy and therapeutic solutions. His sales and business expertise grew during this time. Working with large global organizations and now multiple start-ups Kevin has a diverse perspective on the cardiac industry and healthcare as a business.
Director of Sales & Clinical Development - EMEA & Asia
Richard is responsible for sales and product adoption across Europe and Asia. His focus is on helping hospitals incorporate inHEART into their daily operations to improve clinical decision-making and everyday workflows. Richard's work in the emergency services has taught him to look at the medical field from a caregiver's perspective. Richard has an M.Sc. in Biomedical Engineering, as well as experience at Abbott and Johnson & Johnson / Biosense Webster in sales and electrophysiology, giving him the opportunity to develop a deep understanding of the needs of customers in cardiac rhythm management.
Clinical and Sales Development Manager
Charlotte is responsible for sales and product adoption across Europe for inHEART. Her focus is on helping hospitals incorporate inHEART into their daily operations to improve clinical decision-making and everyday workflows. Her time as Business Development Manager at Corscience for Defibrillators and AEDs provided her with insights into international business, development projects, and customer acquisition. Charlotte has a M.Sc. in Molecular Life Sciences as well as experience at Johnson & Johnson / Biosense Webster in sales and electrophysiology where she developed a deep understanding of the needs of customers in cardiac rhythm management.
Medical Device Commercialization & Marketing Consultant
SPRIG Consulting, LLC is led by Katie Arnold, a strategic marketing professional with 20 years of healthcare experience. Katie has worked with medical technology companies ranging from venture-backed start-ups to Fortune 500 companies. Throughout her career, Katie has focused on the entire spectrum of marketing needs: from early stage market development strategies to downstream launch execution and commercialization efforts. Katie holds a BA from the University of Vermont.
The Region and the European Union are supporting the inHEART project as part of the 2021-2027 ERDF/ESF Operational Programme